SUMMARY
,&Xylosides stimulate 2-to 6-fold the synthesis of glycosaminoglycans by three types of nonconnective tissue cells (RG-C6, NB41A, and rat hepatoma cells, and normal and simian virus 40 (SV40)-transformed normal human skin fibroblasts. The effect, which is specific for the anomeric linkage and the glycone, is observed in the presence and absence of puromycin. /3-Xylosides may substitute for xylosylated core protein as initiators of synthesis of chondroitin sulfate chains. No stimulation of synthesis of heparan sulfate was observed. With the use of a fluorogenic xyloside, 4-methylumbehiferyl-P-n-xyloside, it was demonstrated that the free chondroitin sulfate chains secreted into the medium bear the xyloside at the reducing end, and have an average molecular weight of 16,500.
Most connective tissue glycosaminoglycans are linked to serine residues of a protein core by a xylosylserine bond, which is part of a galactosylgalactosylxylosylserine protein-polysaccharide linkage region (1). The biosynthesis of this linkage region trisaccharide proceeds by the sequential transfer of appropriate monosaccharides by specific glycosyltransferases from uridine nucleotide sugars (2, 3). It has been suggested that the transfer of xylose from UDP-xylose to the protein core (4) regulates the initiation of new polysaccharide chains (5). Telser et al. (6) showed that puromycin inhibits the biosynthesis of sulfated glycosaminoglycans in embryonic chick epiphyseal cartilage, presumably by preventing synthesis of core protein. In the same system, Brett and Robinson (7) demonstrated that puromycin inhibition is reversed by the addition of high concentrations of u-xylose. They suggested that xylose substitutes for core protein as an initiator of chondroitin sulfate chains. It has also been reported that n-xylose partially reverses the inhibition of glycosaminoglycan synthesis in limb bud cells and chondrocytes grown in the presence of Okayama et al. (11) and Okayama and Lowther (12) observed that certain fi-r-xylosides relieve the puromycin inhibition of glycosaminoglycan synthesis in cartilage slices at much lower concentrations than does u-xylose. Similar results were reported by Schwartz et al. (10) in cultures of chondrocytes and limb bud cells treated with puromycin or BrdUrd. Enhancement of chondroitin sulfate synthesis by P-xylosides was also observed in nonconnective tissue cells, which normally synthesize minimal amounts of this glycosaminoglycan.
In this paper, a detailed report of the effect of fi-xylosides on glycosaminoglycan synthesis by three different types of nonconnective tissue cells and by normal and HV40-transformed normal human skin fibroblasts is presented.
EXPERIMESTAL PROCEDURE
Materials-Modified Eagle's medium (13) was obtained from Grand Island Biological Co., and modified Swim's S-77 medium (14) was prepared in this laboratory.
Other materials were obtained from the following sources: fetal calf serum, trypsin (0.25y0 solution), and Hanks' BSS from Grand Island Biological Co.: p-nitrophenyl-a-n-xylopyranoside, p-nitrophenyl-0-nxylopyrano: side. 4-methvlumbellifervl-B-n-xvlonvranoside from Koch-Lieht Laboratories:
4.methylumhellif&y~-i-n-galactopyranoside frim Pierce Chemical Co.; p-nitrophenyl-fl-n-galactopyranoside from Sigma Chemical Co.; puromycin dihydrochloride from Nutritional Biochemicals Co.; gentamycin from Schering Corp.
The radioactive precursors H236SOd, carrier-free, (43 Ci/mg) and sodium [U-3H]acetate (100 Ci/mol) were purchased from New England Nuclear Corp. Varidase was used as a source of streptococcal hyaluronidase, since the preparation is rich in contaminating hyaluronidase.
Commerical Varidase (20,000 units of streptokinase/8 mg) was obtained from Lederle Laboratories. Testicular hyaluronidase (20,000 units/mg) was purchased from Leo-Helsinborg Laboratories, Sweden. Chondroitinase ABC, prepared by Seikagaku Kogyo Co., Ltd., was purchased from Miles Laboratories, Inc. Carrier chondroitin 4-sulfate was a gift of Dr. J. A. Cifonelli. Twice crystallized papain, prepared from crude enzyme (type II Sigma) by the procedure of Kimmel and Smith (15) , was a gift of Dr. A. C. Stoolmiller.
Cell Culture-Rat glial cells (clonal strain RGC6) (16) and mouse neuroblastoma cells (C-1300, clonal strain NB41A) (17) were a gift of Dr. G. Sato. Cells were plated at a density of 5 X 106/100-mm dish, and were fed twice during the following 7 days with 7 ml of modified Eagle's medium supplemented with 10% fetal calf serum and 5 pg/ml of gentamycin. Experiments were usually carried out on the 7th day, when RG-C6 cultures reached a density of 2.5 to 3.5 X lo7 cells/dish and NB41A cultures a density of 2 to 2.5 X lo7 cells/dish.
Rat hepatoma cells (HTC), obtained from Drs. D. Haggerty and G. Popjak, were plated at a density of 5 X 105/100-mm dish with 8 ml of modified Swim's S-77 medium supplemented with 5y0 fetal calf serum and 5yo calf serum. HTC cells were fed every other day, and reached a density of 1.2 to 1.4 X 10' cells/dish after approximately 1 week in culture. Human skin fibroblasts, which had undergone eight transfers, were cultured as described by Matalon and Dorfman(l3) in modi: fied Eagle's medium sunnlemented with 10% fetal calf serum and 10% calf serum.
Cells were plated at a density of 2 X 10"/60-mm dish with 8 ml of medium, and were fed two to three times/week. Cultures--The effect of the addition of various xylosides and galactosides on the synthesis of sulfated glycosaminoglycans by rat glial and mouse neuroblastoma cells is shown in Table I . The results indicate that of the compounds tested, only P-xylosides stimulate sulfate incorporation into glycosaminoglycans. a-Xylosides and P-galactosides have no significant effect, indicating specificity for anomeric linkage and glycone.
When P-xylosides are added to puromycin-treated cultures, is much lower than that required for nxylose to overcome the inhibitory action of puromycin in intact chicken cartilage (7) and of 13rdUrd in limb bud cells and chondrocytes (8-10). The effect of P-xylosides is rapid, being observed within 1 to 2 hours (lo), and its magnitude is not affected by cell density. 1. Dose response of rat glial cells to p-nitrophenyl-p-nxyloside. Rat glial cells (2.4 X lo7 cells/plate) were incubated for 6 hours at 37" with 5 FCi of Hn"%Or/ml of medium (25 &i/plate) containing p-nitrophenyl-P-n-xyloside at concentrations ranging from 0.01 mM to 1 mM. One plate of cells was used for each concentration. Labeled glycosaminoglycans were isolated from pooled cells and media as described by Dorfman and Ho (18 on Sephadex G-50. Fig. 2 illustrates an example of a typical analysis of doubly labeled material isolated from cultures of NB41A incubated in the presence or absence of 4-methylumbelliferyl-b-nxyloside. The isolated material is eluted in the void volume of columns of Sephadex G-50 ( Fig. 2A) . After treatment of this fraction with streptococcal hyaluronidase, the resulting hyaluronate and chondroitin disaccharides are separated from the undigested material in the void volume (Fig. 2B) , and identified by paper chromatography in Solvent 13. Subsequent treatment of the undigested material with chondroitinase AlK allows the identification of the chondroitin 4-and B-sulfate and dermatan sulfate fraction (Fig. 2C) . In separate experiments, testicular hyaluronidase digestion, to which dermatan sulfate is relatively resistant (27)) showed that little dermatan sulfate is synthesized by either NB41A or RG-C6 cells in the presence or absence of P-xylosides, in agreement with the findings of other workers (18, 25, 26) . Paper chromatography, following chondroitinase ABC digestions, demonstrated that in P-xyloside-treated RG-C6 and N1341A cultures, there is an increase only in the chondroitin 4-sulfate disaccharide.
Subsequent to chondroitinase ABC digestions, the residue eluted in the void volume is treated with nitrous acid. Practically all of the 35S-labeled material moves to an included position on Sephadex G-50, while some of the [WH]acetate-labeled material remains in the void volume (Fig. 2D ). This material was not identified as a glycosaminoglycan.
Calculations of glycosaminoglycan content were corrected for the number of counts in this fraction. 2. Gel chromatography of doubly labeled material isolated from control and stimulated NB41A cultures following sequential enzymic and chemical treatments. Samples from control (I) and stimulated (2) cultures were applied to columns (0.8 X 90 cm) of Sephadex G-50, which were eluted with 0.2 M NaCl. Fractions of 1 ml were collected at a rate of 3 to 4 ml/hour. After each run, the void volume fractions were pooled, dialyzed against distilled water, concentrated to a small volume, and submitted to the next treatment. Treatments were done as indicated under "Experimental Procedure " in the following sequence. A, none; B, streptococcal hyaluronidase; C, chondroitinase ABC; D, nitrous acid. The ordinates for Panels 1, A, B, and C are different from those for 2, A, B, and C.
reported to be linked to protein in a manner identical to chondroitin sulfates and dermatan sulfate (28, 29) , is minimally increased. The formation of hyaluronic acid shows little elevation in either RG-C6 or NB41A cultures.
Characterization of Sulfated Glycosaminoglycans from HTC CM&es-Y!-Labeled glycosaminoglycans were isolated from rat hepatoma cultures, following incubation as described in the legend to Table III, and characterized by chondroitinase ABC digestion and nitrous acid degradation.
As shown in Table III and analyzed essentially by the same procedure described previously for doubly labeled material from RG-C6 and NB41A cultures. However, a testicular hyaluronidase digestion was introduced in the sequence of enzymic treatments. The modification was made in order to distinguish chondroitin 4/6-sulfates from dermatan sulfate. However, it should be emphasized that testicular hyaluronidase does attack dermatan sulfate wherever linkage of N-acetylgalactosamine to n-glucuronic acid occurs (30, 31) . For this reason, the distinction is not absolute.
Following streptococcal hyaluronidase digestion of the labeled material isolated from normal and SV40transformed normal fibroblasts and separation of the hyaluronic acid disaccharide fraction, the glycosaminoglycans excluded from the Sephadex G-50 columns were treated with testicular hyaluronidase, and rechromatographed on the same columns. The material eluted in the void volume was considered to be dermatan sulfate, while the included material was designated as the chondroitin 4/6-sulfate fraction. The testicular hyaluronidase-resistant material was then subjected to digestion with chondroitinase ABC to which dermatan sulfate is sensitive (20) .
Only traces of heparan sulfate were found in the labeled material isolated from cells plus media by cetylpyridinium chloride precipitation (18) . Almost all of the heparan sulfate, identified by nitrous acid degradation, was found in the cetylpyridinium chloride-soluble fraction, presumably because of a low degree of sulfation or low molecular weight. Table IV summarizes the results of the analysis of labeled glycosaminoglycans from cultures of normal and SV40-transformed fibroblasts in the presence or absence of 4-methylumbelliferylfl-n-xyloside. In both strains, the fi-xyloside stimulates the incorporation of [UJH]acetate into glycosaminoglycans 2-to 3-fold. Upon analysis, it is found that the synthesis of the chondroitin 4/6-sulfates fraction is stimulated 6-to 7-fold in normal fibroblasts and 23-fold in SV40-transformed fibroblasts. Furthermore, dermatan sulfate synthesis is stimulated about la-fold in normal fibroblasts, while less stimulation is found in the transformed cells.
As expected, hyaluronic acid synthesis is not stimulated in either normal or SV40-transformed fibroblasts. Only a a-fold stimulation is observed in the heparan sulfate fraction of normal fibroblasts, while no stimulation is found in SV40-transformed cells. This result is similar to what was reported above for RG-C6, NB41A, and HTC cultures. demonstrated that chondroitin sulfate chains synthesized by cartilage in the presence of 4-methylumbelliferyl-fi-D-xyloside bear the syloside at the reducing end of the chains. A similar result was obtained by Levitt (32) utilizing radioactive xylose. Table V shows the distribution of radioactivity and of 4-methylumbelliferol (determined after hydrolysis) in fractions of RG-C6 cultures. The fluorescent material was found associated with sulfated glycosaminoglycaus present predominntly in the medium.
When dialyzed media from control and 4-methylumbelliferyl-P-D-xyloside-treated RG-C6 cultures were chromatographed on a column of Sephadex G-200, the patterns illustrated in Fig.  3 were obtained. While the labeled material from control cultures was eluted mostly in the void volume of the column (Fig.   3A) , the material from stimulated cells was eluted in a broad peak in the included volume (Fig. 3B) . This peak was coincident with the peak of fluorescence obtained after hydrolysis of the samples.
When the labeled material from control cultures was treated with alkali (24) and rechromatographed on Sephadex G-200, the radioactivity was eluted in an included position (Fig. 3A) . Based on the elution volume, an average molecular weight of about 20,000 was calculated for this material (33). Similar calculations gave an average molecular weight of about 12,500 for the material from the stimulated cultures. For this material, it was also possible to calculate the average number of disaccharide units from the molar ratio of glucuronic acid (0.125 pmol/ml) to 4-methylumbelliferol (0.0037 pmol/ml). This ratio of 33 corresponds to an average molecular weight of 16,500. 3. Gel chromatography of media from RG-C6 cultures incubated in presence or absence of 4-methylumbelliferyl-P-nxyloside.
Fourteen plates of rat glial cells (3.7 X lo7 cells/plate) were incubated for 6 hours at 37" in the presence (B) or absence (A) of 0.1 mM 4-methylumbelliferyl-P-n-xyloside.
Six plates in each group were labeled with 5 &i of H235SOd/ml of serum-free medium (25 &i/plate). Media in each group were combined, dialyzed for 8 hours against Na&O+ and then for 5 days against water, concentrated to 8 ml, and applied to a column (2 X 130 cm) C-5 of already polymerized n-glucuronic acid residues of chonxylose or @-n-xylosides.
droitiii sulfate chains (44). This problem was examined in normal and SV40-transformed normal fibroblasts. P-Xylosides caused a Analysis of the product formed in the presence of the fi-xylostimulation of chondroit,in 4-and 6-sulfate production in both side shows that following initiation, chain assembly also occurs. cell types, while the stimulation in the dcrmatan sulfate fraction Thus, the fl-xylosides arc used not only as substrates for the (13.fold) was found only in normal fibroblasts (Table IV) . The first galactosyltransferase reaction, but induce formation of lack of P-xylosidc stimulation of dermatan sulfate synthesis in complete chondroitin sulfate chains. That the chondroitin sultransformed normal fibroblasts may reflect a limitation of the fate chains produced under the influence of 4-methylumbellirate of epimerization, thus preventing conversion of chondroitin sulfate to dermatan sulfate in these cells, while permitting a greater accumulation of chondroitin sulfate chains than in normal cells. Alternatively, these findings may be a result of the relative distribution and content of L-iduronic acid and n-glucuronic acid residues in dermatan sulfate produced by SV40-transformed cells in the presence of /3-xylosides, which could make the molecule sensitive to testicular hyaluronidase and result in spuriously high chondroitin sulfate values. The results of analyses of the heparan sulfate fraction in both normal and SV40-transformed fibroblasts are in accord with the failure of xylosides to stimulate the synthesis of this polysaccharide in other cell types. All cultures examined produce large amounts of hyaluronic acid, but the addition of fl-xylosides does not affect this component, which might be expected, in view of the fact that a xyloside linkage to a protein core has never been reported for this glycosaminoglycan.
@-Xylosides, with their property of stimulating synthesis of glycosaminoglycan chains, may be used as specific probes to assay the potential of a particular cell to produce chondroitin sulfate chains, and therefore, provide a method for separating the cellular capacity to produce polysaccharide chains from xylosylated core protein. Labeling the reducing end of chondroitin sulfate chains with a fluorogenic xyloside, 4-methylumbelliferyl-P-n-xyloside, and the growing chains with radioactive precursors, like Hz3%04 and [ U-3H]acetate, may soon provide some answers about the mechanisms of chain elongation, sulfation, and termination.
